We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $201M
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$240M
AUM Growth
+$16.6M
Cap. Flow
-$5.83M
Cap. Flow %
-2.43%
Top 10 Hldgs %
37.1%
Holding
98
New
2
Increased
22
Reduced
48
Closed
2

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$342K
2
NKE icon
Nike
NKE
+$282K
3
ILMN icon
Illumina
ILMN
+$244K
4
IP icon
International Paper
IP
+$207K
5
NVDA icon
NVIDIA
NVDA
+$207K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$1.19M
2
DIS icon
Walt Disney
DIS
+$921K
3
PYPL icon
PayPal
PYPL
+$916K
4
MDT icon
Medtronic
MDT
+$838K
5
ADP icon
Automatic Data Processing
ADP
+$287K

Sector Composition

Rank Sector Weight
1 Healthcare 26.95%
2 Technology 23.6%
3 Industrials 13.84%
4 Consumer Staples 8.36%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
1
Automatic Data Processing
ADP
$102B
$11.9M 4.93%
49,622
-1,168
-2% -$287K
AAPL icon
2
Apple
AAPL
$4.95T
$10.5M 4.37%
80,837
-1,534
-2% -$219K
MA icon
3
Mastercard
MA
$487B
$9.42M 3.92%
27,093
+33
+0.1% +$10.9K
JNJ icon
4
Johnson & Johnson
JNJ
$641B
$9.3M 3.87%
52,641
-9
-0% -$1.55K
ABT icon
5
Abbott
ABT
$182B
$8.96M 3.73%
81,608
+37
+0% +$3.83K
PG icon
6
Procter & Gamble
PG
$346B
$8.88M 3.7%
58,574
+329
+0.6% +$46.1K
MSFT icon
7
Microsoft
MSFT
$2.89T
$7.82M 3.25%
32,591
+93
+0.3% +$22.3K
DHR icon
8
Danaher
DHR
$138B
$7.63M 3.17%
32,407
-243
-0.7% -$56.3K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$3.99T
$7.46M 3.11%
84,557
+294
+0.3% +$27.9K
CNI icon
10
Canadian National Railway
CNI
$78B
$7.29M 3.03%
61,311
+913
+2% +$109K
ADI icon
11
Analog Devices
ADI
$181B
$6.75M 2.81%
41,153
-741
-2% -$116K
ROK icon
12
Rockwell Automation
ROK
$51.9B
$6.52M 2.71%
25,303
+324
+1% +$81.3K
RTX icon
13
RTX Corp
RTX
$294B
$6.33M 2.64%
62,729
+999
+2% +$94K
ATR icon
14
AptarGroup
ATR
$8.51B
$5.81M 2.42%
52,840
+993
+2% +$102K
CVS icon
15
CVS Health
CVS
$137B
$5.1M 2.12%
54,691
+103
+0.2% +$9.94K
FISV
16
Fiserv Inc
FISV
$27.9B
$5M 2.08%
49,478
+198
+0.4% +$19.7K
ABBV icon
17
AbbVie
ABBV
$454B
$4.82M 2.01%
29,800
-400
-1% -$61.3K
XOM icon
18
ExxonMobil
XOM
$642B
$4.76M 1.98%
43,187
-632
-1% -$67.7K
HD icon
19
Home Depot
HD
$335B
$4.24M 1.76%
13,416
+16
+0.1% +$4.87K
TJX icon
20
TJX Companies
TJX
$173B
$4.13M 1.72%
51,844
+408
+0.8% +$30.1K
NVS icon
21
Novartis
NVS
$297B
$3.96M 1.65%
43,681
-15
-0% -$1.26K
PEP icon
22
PepsiCo
PEP
$191B
$3.96M 1.65%
21,922
-166
-0.8% -$29.6K
UNH icon
23
UnitedHealth
UNH
$379B
$3.44M 1.43%
6,495
+136
+2% +$72K
NVDA icon
24
NVIDIA
NVDA
$4.76T
$3.42M 1.42%
233,930
+14,110
+6% +$207K
BDX icon
25
Becton Dickinson
BDX
$43.8B
$3.21M 1.33%
12,606
+1,450
+13% +$342K

Similar funds

Notis-McConarty Edward's Q4 2022 Portfolio in Review

As of Q4 2022, Notis-McConarty Edward held 98 positions worth $240M, up 7.4% from $224M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.1%. Notis-McConarty Edward opened 2 new positions and exited 2, leaving the 98-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • Notis-McConarty Edward's largest Q4 2022 buy was International Paper: 6,000 shares worth $208K.
  • Notis-McConarty Edward added most to Becton Dickinson in Q4 2022, an estimated $342K increase.
  • Notis-McConarty Edward's biggest Q4 2022 reduction was Unilever, cutting an estimated $1.19M.
  • Notis-McConarty Edward fully exited State Street SPDR S&P 500 ETF Trust in Q4 2022, selling an estimated $230K.
  • Notis-McConarty Edward's ten largest holdings make up 37% of its $240M portfolio in Q4 2022.
  • Notis-McConarty Edward opened 2 new positions and closed 2 in Q4 2022.
  • Notis-McConarty Edward's portfolio value rose 7.4% quarter-over-quarter to $240M.

Based on Notis-McConarty Edward's 13F filing for Q4 2022, filed 9 Feb 2023.